Location History:
- Naupada, IN (2008)
- Mumbai, IN (2017)
Company Filing History:
Years Active: 2008-2017
Title: **Innovator Spotlight: Rajesh Ganpat Bhopalkar of Mumbai**
Introduction
Rajesh Ganpat Bhopalkar is a distinguished inventor based in Mumbai, India. He is recognized for his significant contributions to the field of pharmaceuticals, holding two patents that address important medical needs. His innovative work showcases the intersection of chemical processes and therapeutic applications, aiming to improve patient outcomes.
Latest Patents
Rajesh's latest patents focus on the synthesis of valuable pharmaceutical compounds. One of his notable inventions is the synthesis of Dabigatran etexilate, which involves a unique process for preparing this anticoagulant or its pharmaceutically acceptable salt. The patent also introduces novel compounds, including Ethyl-3-{[(2-formyl-1-methyl-1H-benzimidazole-5-yl)carbonyl]-(2-pyridinyl) amino}propanoate and Ethyl-3-{[(2-dichloromethyl-1-methyl-1H-benzimidazole-5-yl)carbonyl]-(2-pyridinyl)amino}propanoate, and details their use in the preparation of Dabigatran etexilate.
Additionally, Rajesh has developed a process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride, commonly known as Ropinirole. This invention includes a novel process and novel intermediates, along with a pharmaceutical composition comprising Ropinirole that provides a method of treatment for cardiovascular disorders and Parkinson's disease.
Career Highlights
Rajesh Bhopalkar is currently employed at USV Private Limited, a well-known pharmaceutical company. His work is pivotal in advancing the company's research and development initiatives. With a strong focus on therapeutic solutions, Rajesh’s inventions reflect his commitment to tackling significant health challenges through innovative science.
Collaborations
Throughout his career, Rajesh has collaborated with notable colleagues such as Harish Kashinath Mondkar and Venkatasubramanian Radhakrishna Tarur. These partnerships have fostered a productive environment for research and have undoubtedly contributed to the successful outcomes of their projects.
Conclusion
Rajesh Ganpat Bhopalkar stands out in the field of pharmaceutical innovation through his patents that underline the potential of novel compounds in treating serious health conditions. His work at USV Private Limited and collaborations with fellow innovators epitomize the impact of dedicated research and development in enhancing medical therapies. Rajesh's contributions not only advance scientific knowledge but also aim to improve the lives of patients worldwide.